121 
0 Kommentare
Teva's 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets
Teva exceeded all sustainability-linked bond targets, linking financial performance to expanded patient access to medicines and reduced environmental impact.Through its global access to medicines programs, Teva reached nearly 8 million people …
-
Teva exceeded all sustainability-linked bond targets, linking financial performance to expanded patient access to medicines and reduced environmental impact.
-
Through its global access to medicines programs, Teva reached nearly 8 million people through product donations around the world.
39% reduction in Teva's Scope 1 and 2 GHG emissions since 2019 and 32% reduction in Scope 3 GHG emissions since 2020-exceeding 25% reduction targets.
More than 99% of active employees completed compliance and ethics training.
Teva's generic medicines contributed $36.4 billion in savings for healthcare systems across 21 countries.
TEL AVIV, IL / ACCESS Newswire / April 30, 2026 / Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today published its 2025 Healthy Future Report, outlining performance against its sustainability targets, which are focused on the issues most relevant to its business, patients and the planet. Teva surpassed all 2025 targets associated with its sustainability-linked bonds-totaling approximately $7.5 billion across its 2021 and 2023 issuances. These commitments reflect progress in areas such as climate action, health equity and access to medicines, linking financial and sustainability performance.
"Advancing sustainability is fundamental to how we operate at Teva," said Richard Francis, Teva's President and CEO. "Our 2025 Healthy Future Report shows how we're building the future we want to see-addressing global challenges by using our footprint, resources and skills to drive meaningful impact for our business and stakeholders."
Healthy People
Teva operates eight access to medicines programs focused on delivering life-changing treatments to underserved populations. Several programs incorporate health system strengthening and capacity-building components, reflecting a holistic approach to improving health outcomes. Through these efforts, Teva reached nearly 8 million people with product donations and approximately 399,000 people through health system strengthening initiatives worldwide.
Healthy Planet
Teva reduced greenhouse gas (GHG) emissions from its operations (Scopes 1 and 2) by 39% since 2019, surpassing its 25% target. The Company also reduced GHG emissions from its value chain (Scope 3)-which account for approximately 90% of its total GHG emissions-by 32% since 2020, exceeding its 25% target ahead of schedule. Teva continued transitioning to cleaner energy, with 60% of total electricity consumption sourced from renewables and 100% renewable electricity via three long-term power purchase agreements to date, which cover various Teva sites in Europe and Israel. In addition, 73% of applicable Teva sites reached safe discharge levels of antimicrobials-helping address antimicrobial resistance (AMR), a growing global health threat that reduces the effectiveness of medicines and makes infections harder to treat.
Diskutieren Sie über die enthaltenen Werte
URL kopieren
Per E-Mail teilen
Artikel drucken